Skip to main content
Caplight Logo









MYDAWA

MYDAWA

Private
NairobiHealthcare & Life Scienceshttps://mydawa.com

Last Round

Early Funding

May 6, 2025

Total Funding Raised

$18.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MYDAWA operates in Healthcare & Life Sciences and is based in Nairobi. Its latest recorded funding round was an Early Funding round in May 2025.

MYDAWA is a health-tech company that operates an online pharmacy and telehealth platform for the sale of authentic medicines, health, and wellness products in Kenya.

Sector

Healthcare & Life Sciences

Verticals

E-commerce, Telemedicine, Pharma Supply Chain, Last-Mile Delivery

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MYDAWA Comparables

Compare MYDAWA with similar companies based on industry and business-model similarity.

MYDAWA comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Dawaai
79%
OneHealth
79%
Chefaa
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MYDAWA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 6, 2025
VC RoundJul 3, 2023
GrantDec 2, 2021
Series AMay 7, 2019
SeedMar 28, 2017
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Mouhamad Kawas

Group Chief Technology Officer (Group CTO)

Executive Team

Tony Wood

Group Chief Corporate Development Officer

Executive Team

For institutional investors. Book with your work email.

MYDAWA Investors

Notable investors and investment history

MYDAWA investors
InvestorRounds
Impact Fund DenmarkEarly Funding
AAIC InvestmentEarly Funding
Gates FoundationGrant
CreadevEarly Funding
Investing in Innovation (i3) AfricaEarly Funding
Alta Semper CapitalEarly Funding, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 70% MoM.

  • May 6, 2025

    Priscilla Muhiu, formerly GM of Glovo Kenya, named new CEO.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • is_developingOct 7, 2026

    In Nov '26, MYDAWA Limited and Endless Health jointly develop and test a digital-first model that makes hypertension and diabetes care more accessible for low- and middle-income patients through digital health services.

  • is_developingSep 29, 2026

    MYDAWA Limited has partnered with Endless Health and Ariadne Labs to develop and test a digital-first model for hypertension and diabetes care through private pharmacies in East Africa, aiming to generate evidence on the quality of care delivered through that channel.

  • partners_withSep 29, 2026

    MYDAWA Limited is partnering with Turn, a WhatsApp-based engagement platform, to make communication with patients easier and more accessible.

  • partners_withSep 29, 2026

    MYDAWA Limited and Endless Health, Inc. signed a partnership to co-design, test, and document a scalable, digital-first model of hypertension and diabetes care for low- and middle-income patients.

  • partners_withSep 29, 2026

    MYDAWA Limited has partnered with Ariadne Labs to develop and test a digital-first model for hypertension and diabetes care through private pharmacies in East Africa.

Book a demo to see all news

For institutional investors. Book with your work email.

MYDAWA Filings

Explore SEC and related filing metadata, where available.

MYDAWA filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MYDAWA's valuation, stock price, and market status.

Is MYDAWA a public or private company?

MYDAWA is a private company.

What is the current stock price of MYDAWA?

MYDAWA is a private company, so its shares have no public market price. Caplight tracks MYDAWA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MYDAWA worth (valuation)?

Valuation information for MYDAWA is not publicly available.

Can I buy MYDAWA stock?

MYDAWA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MYDAWA's last funding round?

MYDAWA's most recent funding round was Early Funding on May 6, 2025.

Who are the main investors in MYDAWA?

Key investors in MYDAWA include Impact Fund Denmark, Alta Semper Capital.

Will MYDAWA IPO soon?

No public IPO plans have been announced for MYDAWA.

How can I track MYDAWA secondary market activity?

Caplight tracks bids, offers, and trades in MYDAWA's shares on secondary markets.

Firmographic Details

HeadquartersNairobi
Employee Range128
Year Founded2017
Last FundingMay 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?